An urban gardening program has received $3.4 million to reduce food insecurity in the Dominican Republic – and was also found to greatly improve HIV outcomes.
The number of people contracting autoimmune diorders in the United Kingdom is growing, including diseases like type 1 diabetes and rheumatoid arthritis. But why?
Prof. Hartmut J. Ehrlich, MD, CEO of Abivax, explains why the Company’s drug candidate, obefazimod, has the potential to treat Inflammatory Bowel Diseases.
Dr. Ludivine Herman, Project Leader at immunotherapy specialist Imcyse, walks us through Neuoromyelitis optica facts & trends, the challenges of current therapies and the potential of immunotherapies.
Ruplekha Choudhurie, Senior Industry Analyst/Team Lead, walks us through nanomedicine, explaining a multipronged approach to tackle infectious diseases.
Personalised medicine has become essential in practically every field of healthcare, but tailored medicine is extremely vital when it comes to organ transplantation.
Dr Samantha Walker, Director of Research and Innovation at Asthma + Lung UK, explains why prioritising lung research is the best way to improve the nation’s health.
Link established between western diets high in fat and sugar and the development of non-alcoholic fatty liver disease, the leading cause of chronic liver disease.
Paul Sommerfeld, Executive Trustee, TB Alert and Chair, TB Europe Coalition, walks us through tackling tuberculosis. We hear that while there are continuing problems, there are finally grounds for optimism.
